Employees: 19,687
Size China Resources Medical (1515.HK) is a Hong Kong Health Care company (Hospital/Nursing Management) with a market value of $393M, the 819th largest of 885 Hong Kong companies the cockpit tracks. Shares closed at HK$2.43 on 18 Nov 2026.
Performance Over six months the shares fell 9.7%, against -3.4% for the median peer and -14.0% for the Hong Kong market (cap-weighted) — 7th lowest of 19 in its peer set.
Growth Revenue grew 0.4% over the last twelve months (peer median +11.9%); the operating margin is 5.9% (peer median 10.7%).
Valuation It trades at 5.4× forward earnings against a peer median of 22.5× (cheapest of 14).
Price implies For today's price to make sense, revenue must grow about -7% a year for seven years (Req g). Recent delivered growth is +26%, so the hurdle is -34 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 3.3 points below its cost of capital (8.2% WACC).
Next results Next results expected around 30 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | HK$10.2B | HK$9.95B | HK$10.7B | HK$11.2B | HK$9.19B |
| Revenue growth | — | -7% | -4% | +22% | — |
| Gross profit | HK$1.40B | HK$1.56B | HK$1.96B | HK$2.11B | HK$1.52B |
| EBITDA | HK$1.26B | HK$1.09B | HK$1.49B | HK$1.56B | HK$1.09B |
| Net income | HK$473M | HK$538M | HK$614M | HK$285M | HK$309M |
| Free cash flow | HK$767M | HK$1.07B | HK$702M | HK$768M | HK$435M |
| Capital expenditure | HK$627M | HK$554M | HK$611M | HK$538M | HK$542M |
| Total debt | n/a | HK$950M | HK$1.70B | HK$2.54B | HK$2.70B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 1515.HK | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +2.1% | -2.1% | 10th highest of 20 |
| 6-month return | -9.7% | -3.4% | 7th lowest of 19 |
| Distance from 52-week high | -30.0% | -18.4% | 8th lowest of 21 |
| Revenue growth (TTM) | +0.4% | +11.9% | 2nd lowest of 21 |
| Operating margin | 5.9% | 10.7% | 5th lowest of 21 |
| Forward P/E | 5.4× | 22.5× | cheapest of 14 |
| Growth the price implies (Req g, 7 yrs) | -7.5% | 7.2% | least demanding of 17 |
| Growth delivered (Del g) | +26.3% | +15.5% | highest of 17 |
| Hurdle (Req g minus delivered) | -33.8 pp | -4.9 pp | least demanding of 17 |
| ROIC minus cost of capital | -3.3 pp | +1.1 pp | 5th lowest of 21 |
| EV / EBITDA | 3.5× | 14.6× | cheapest of 18 |
| Net debt / EBITDA | -0.2× | 0.6× | 4th least indebted of 18 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| China Resources Medical 1515.HK | Hong Kong | $393M | -10% | 0% | 6% | 5.4× | -7.5% | +26.3% |
| Voxel VOX.WA | Poland | $393M | +59% | +14% | 24% | 13.6× | 1.2% | +12.2% |
| Charm Care 6062.T | Japan | $402M | +57% | +6% | 11% | 15.3× | -0.4% | +16.4% |
| Bright Eye Hospital 301239.SZ | China | $377M | -26% | +11% | 9% | 41.5× | -5.1% | +15.5% |
| Bayzed Health 2609.HK | Hong Kong | $375M | -58% | -2% | 5% | n/a | 14.7% | +9.2% |
| Indraprastha Medical INDRAMEDCO.NS | India | $351M | 0% | +11% | 15% | 15.9× | 14.9% | +19.3% |
| KMC Speciality Hospitals (India) KMCSHIL.NS | India | $346M | n/a | +35% | 23% | n/a | 19.0% | +24.4% |
| Liaoning He Eye Hospital 301103.SZ | China | $342M | -20% | +3% | 4% | n/a | -4.2% | +5.4% |
| Viemed Healthcare VMD | United States | $333M | -9% | +22% | 8% | 17.4× | 6.8% | +15.5% |
| Q & M Dental Group (Singapore) QC7.SI | Singapore | $326M | -26% | +16% | 9% | 31.6× | 7.7% | +7.5% |
| Garofalo Health Care GHC.MI | Italy | $508M | -3% | +4% | 10% | 20.5× | 1.7% | +18.3% |
| Artemis Medicare Services ARTEMISMED.NS | India | $582M | +25% | +15% | 13% | 42.3× | 48.5% | +21.5% |
| Kovai Medical Center & Hospital KOVAI.NS | India | $759M | +22% | +17% | 21% | n/a | 17.4% | +18.1% |
| Thomson Medical A50.SI | Singapore | $923M | -18% | +6% | 10% | n/a | 21.2% | +11.8% |
| HealthCare Global Enterprises HCG.NS | India | $955M | -7% | +13% | 8% | 88.8× | n/a | n/a |
| Paras Healthcare PARASHLTH.NS | India | $962M | n/a | +24% | 11% | n/a | n/a | n/a |
| Ramsay Generale de Sante GDS.PA | France | $969M | -25% | +3% | 4% | n/a | 6.1% | +6.0% |
| Clinica Baviera CBAV.MC | Spain | $1.01B | +2% | +11% | 20% | 20.1× | 2.3% | +19.7% |
| Jupiter Life Line Hospitals JLHL.NS | India | $1.01B | +9% | +17% | 16% | 48.8× | n/a | n/a |
| Rhon-klinikum RHK.DE | Germany | $1.06B | +15% | +4% | -51% | 22.5× | n/a | n/a |
| Park Medi World PARKHOSPS.NS | India | $1.10B | -4% | +21% | 21% | 30.6× | 22.1% | +10.2% |